Warnex to Distribute DeCode Genetics Tests in Canada | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Warnex today said that it has signed an agreement to serve as exclusive distributor of 10 of DeCode Genetics' tests in Canada.

Most of the DNA-based tests are for assessing risk of developing certain diseases. The tests will be sold by the Warnex Medical Laboratories division of the Laval, Quebec-based firm.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.